Monivent AB (XSAT:MONI) Gross-Profit-to-Asset % : 9.26% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Monivent AB Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Monivent AB's annualized Gross Profit for the quarter that ended in Mar. 2024 was kr1.37 Mil. Monivent AB's average Total Assets over the quarter that ended in Mar. 2024 was kr14.77 Mil. Therefore, Monivent AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 9.26%.

Monivent AB Gross-Profit-to-Asset % Historical Data

The historical data trend for Monivent AB's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monivent AB Gross-Profit-to-Asset % Chart

Monivent AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

45.63

28.14

8.15

2.91

9.55

Monivent AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															12.90	4.36	12.34	16.01	9.26

Competitive Comparison of Monivent AB's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Monivent AB's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Monivent AB's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Monivent AB's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Monivent AB's Gross-Profit-to-Asset % falls into.

Monivent AB Gross-Profit-to-Asset % Calculation

Monivent AB's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2022 )	/	( (Total Assets (A: Dec. 2021 )	+	Total Assets (A: Dec. 2022 ))	/ count )
	=	2.111	/	( (22.925	+	21.294)	/ 2 )
	=	2.111	/	22.1095
	=	9.55 %

Monivent AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2024 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	1.368	/	( (14.276	+	15.261)	/ 2 )
	=	1.368	/	14.7685
	=	9.26 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Monivent AB Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Monivent AB's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Monivent AB (XSAT:MONI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Monivent AB (XSAT:MONI) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Regnbagsgatan 8B, Gothenburg, SWE, SE-417 55

Website

https://www.monivent.se

Monivent AB is a medtech company focused on improving the care given to newborn babies in need of respiratory support at birth. The company has developed a patented solution that provides continuous feedback on the volumes of air given to the newborn during manual ventilation. The airflow is measured directly in the face mask and feedback on the ventilation parameters is displayed numerically and graphically in real-time on the external monitor. The company's product is Monivent Neo100.